25 Comments
 

HL RX is going to be the best group there; HL also has a solid power and utilities team based there. HW has a consumer team. Lazard is only MM and should not be compared to other LAZ offices. Also a few smaller regional shops to consider (Hennepin, TripleTree, Cherry Tree)

Culture is going to be better at these offices than most NYC counterparts. Have heard the HL team is a very chill office (shorts and t shirts), but quite sweaty so you'll work for it. 

 

What’s Lazard’s reputation been like the last 10 years? I heard they have lost some senior bankers there. Is the amount of talent at Lazard MPLS the same as a houlihan per se? What direction do you see those firms going in in the next 10 years?

 

For Laz the reputation of the MM group is quite a bit different. As I mentioned it's a completely different business model. They seem to do fine and compete with most MMs you've heard of. Would give HL the edge on talent, especially for RX

 
Most Helpful

All grind on people and certain groups are frequent 90-100 hour weeks (Piper HCIT, Laz Food)

HL - best overall office in terms of deal quality, reputation, etc. Rx and Industrials.

Piper - largest office with some major teams (Medtech, HCIT, Industrials) that compete well in the MM and beyond (Medtech competes against BBs)

Laz MM - still have some very strong senior bankers, but lots of recent turnover and that office is bound to get wound down in the next few years based on who else is likely to retire. Laz parent has no interest or commitment to sub-$1B deals.

HW - competitive in consumer (mostly Food & Bev) and seems to be growing its presence, though not rapidly. Seems like a good long-term place to be.

BMO office is basically dead at this point. Will likely be shuttered within a year or two. Then you have boutiques after that.

 

I’ve heard good things from friends at TripleTree (Healthcare-focused). They get worked like a mule but have great exit ops (mid-top tier PE, UHG Corp Dev, UHG CorpFin, etc.). Their Avg. deal size is ~$700m with a few per year exceeding $2-3bn. They recently (in past 2 years) have had a $7-8bn transaction.

 
[Comment removed by mod team]
 

IB Intern Monkey

I’ve heard good things from friends at TripleTree (Healthcare-focused). They get worked like a mule but have great exit ops (mid-top tier PE, UHG Corp Dev, UHG CorpFin, etc.). Their Avg. deal size is ~$700m with a few per year exceeding $2-3bn. They recently (in past 2 years) have had a $7-8bn transaction.

That's skewed heavily towards deals they are Co-advisors on. The ones they lead are lower, particularly on a median basis. They are a solid shop in HCIT, but have struggled with the downturn, similar to others (e.g., Blair, Piper). I've always felt comp was below street, but no idea how that's changed after Capital One. Talk about a weird relationship - TT gets literally nothing from Capital One, but provides a lot. I'd be shocked if MDs stuck around more than another year or two.

Also, UHG Corp Dev is atrocious. You work banker hours for half the pay. Not a place anyone should want to be unless you can't make it in IB.

 

Outside of laughing at the UNH exit opp comment, someone did give good perspective around a lot of MPLS IB groups being a grind across firms. Probably a testament to the strength of the groups across all the banks that have people sitting up there.

Healthcare groups in particular see a lot of activity. Minneapolis is underrated relative to all the large cap strategics that have a heavy presence in the metro (3M, UNH, Medtronic, CAH)

 

Doloremque dolor debitis dolorem error ea laudantium minus. Assumenda est odio est laboriosam sed. Fugiat atque quam non. Vero consectetur doloremque officia ratione.

Accusantium ut harum et omnis. Voluptatum aut eum et quod fuga ut ut. Molestiae eum laboriosam consequatur quo.

Maiores ullam et provident enim. Adipisci aut velit eaque nobis voluptas rem nobis. Tempore porro velit illum ut hic quasi esse. Ex autem iusto nisi totam animi sunt commodi.

Quo doloremque itaque nobis. Aut explicabo fuga dicta assumenda sint sequi. Dolores vel blanditiis facere consequatur quasi praesentium culpa est. Quia ratione illum unde eos totam soluta.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (67) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
DrApeman's picture
DrApeman
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
GameTheory's picture
GameTheory
98.9
8
dosk17's picture
dosk17
98.9
9
CompBanker's picture
CompBanker
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”